Background Many opioid-dependent people in prison experience unplanned opioid withdrawal upon entry into custody and face high rates of relapse, opioid overdose, & even death following custody release. The aim of the study was to examine and compare the effectiveness of depot buprenorphine and buprenorphine-naloxone sublingual treatments following custody release.
No takes yet. Share an insight, caveat, or question.
Mlilo et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: